Previous Close | 24.64 |
Open | 25.67 |
Bid | 25.89 x 1000 |
Ask | 25.92 x 1000 |
Day's Range | 25.12 - 26.12 |
52 Week Range | 20.76 - 33.00 |
Volume | 241,240 |
Avg. Volume | 208,843 |
Market Cap | 991M |
Beta (3Y Monthly) | 0.66 |
PE Ratio (TTM) | 590.00 |
EPS (TTM) | 0.04 |
Earnings Date | Feb 11, 2020 - Feb 17, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | 2015-12-09 |
1y Target Est | 35.20 |
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections. The E-nya thoracic stent graft will be manufactured at the Company's facility in Hechingen, Germany.
TORONTO, Nov. 27, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended September 30, 2019. Selected.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of CryoLife, Inc...
Q3 2019 CryoLife Inc Earnings Call
CryoLife (CRY) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
ATLANTA , Oct. 30, 2019 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase ...
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATLANTA , Oct. 16, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter financial results will ...
Today we'll evaluate CryoLife, Inc. (NYSE:CRY) to determine whether it could have potential as an investment idea. In...
ATLANTA , Sept. 18, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat ...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.
NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into distribution and credit facility agreements with Endospan, as well as an option agreement to purchase Endospan. Endospan is an Israeli-based, privately-held developer of NEXUS™, the only endovascular stent graft system approved for the repair of both aneurysms and dissections in the aortic arch. The addition of NEXUS to CryoLife's highly differentiated branched aortic stent graft portfolio further strengthens the Company's position as a leader in the growing aortic repair market.
ATLANTA , Aug. 29, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming investor ...
TORONTO, Aug. 29, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended June 30, 2019. Selected.
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Overhyped toxic stocks are vulnerable to external shocks and burdened with huge amount of debt.
Q2 2019 CryoLife Inc Earnings Call
Vancouver, British Columbia--(Newsfile Corp. - August 2, 2019) - Cryptologic Corp. (CSE: CRY) is one of the latest new listings on the Canadian Securities Exchange, having previously traded as Vogogo under the symbol "VGO'.For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Cryptologic" in the search box. Cannot view this video? Visit:http://www.investmentpitch.com/video/0_u0x68kvb/New-Listing-Cryptologic-Corp-CSECRYJohn Kennedy FitzGerald, President ...
CRY earnings call for the period ending June 30, 2019.
CryoLife (CRY) delivered earnings and revenue surprises of 37.50% and 0.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
ATLANTA , July 30, 2019 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Total revenues were $71.1 million in the second quarter of 2019, reflecting year over year growth of 4% and a 7% ...
NEW YORK, NY / ACCESSWIRE / July, 30 2019 / CryoLife, Inc. (NYSE: CRY ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July, 30 2019 at 4:30 PM Eastern Time. ...
ATLANTA , July 25, 2019 CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Canaccord Genuity ...